Skip to content

Trial of combination of polyethylene glycol with or without sodium picosulphate for treatment of constipation in children

Randomized double blind placebo controlled trial of polyethylene glycol electrolyte solution with or without sodium picosulphate for home based disimpaction in pediatric functional constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011262
Enrollment
94
Registered
2018-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K590- Constipation

Interventions

Intervention1: Sodium picosulfate with Polyethylene glycol: Polyethylene glycol is an osmotic laxative Sodium picpsulfate is a stimulant laxative Dose of polyethylene glycol- ( 1 sachet contains 6.5g

Sponsors

JIPMER intramural grants committee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients between 1 year to 12 years of age attending the pediatric gastroenterology OPD in JIPMER who are diagnosed to have Functional Constipation by Rome IV criteria with impaction [by encopresis, abdominal fecoliths â?? No digital rectal examination (DRE), abdominal radiography will be done for diagnosing impaction] who are planned for disimpaction

Exclusion criteria

Exclusion criteria: (1) Children who have received other drugs for constipation in the past 48 hours (2) Known allergy to any of the drugs

Design outcomes

Primary

MeasureTime frame
Time to disimpaction in daysTimepoint: on the seventh day after starting treatment

Secondary

MeasureTime frame
Dose of PEG in sachets required for disimpaction, vomiting, abdominal distension necessitating drug discontinuation, pain abdomen, features of electrolyte abnormalities or intestinal obstruction, increase in encopresis, failure to disimpact after 7 days, complianceTimepoint: on the seventh day after starting treatment

Countries

India

Contacts

Public ContactDr Barath Jagadisan

JIPMER

barathjag@yahoo.com9487572724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026